Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

Venus Remedies has received marketing authorization from Indonesia for its Enoxaparin, an anticoagulant, in pre-filled syringes. The approval reinforces the company's presence in Southeast Asia and ...

Venus Remedies has received marketing authorization from Indonesia for Enoxaparin, an anticoagulant in pre-filled syringes. This approval strengthens its presence in Indonesia, a country with high ...

A proposal to prohibit the use of second-generation anticoagulant rodenticides or SGARs on city-owned property is coming ...

The pharmaceutical company informed the stock exchanges in a filing that it has received marketing authorisation for ...

IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

Researchers have found in a cohort study that patients with atrial fibrillation (AF) receiving a factor Xa inhibitor and ...